Somatropin Market, by Dosage Form (Powder, Solvent), by Application (Growth Hormone Deficiency (GHD), Turner Syndrome, Chronic Renal Insufficiency, Prader Willi Syndrome, Small for Gestational Age, SHOX Deficiency, Others), by Distribution Channel (Hospit

Somatropin Market, by Dosage Form (Powder, Solvent), by Application (Growth Hormone Deficiency (GHD), Turner Syndrome, Chronic Renal Insufficiency, Prader Willi Syndrome, Small for Gestational Age, SHOX Deficiency, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Somatropin injection is used to replace growth hormone (a natural hormone produced by body) in adults and children with growth hormone deficiency. Somatropin injection is also used to increase growth in children with certain conditions that affect normal growth and development. Somatropin injection comes as a solution (liquid) in prefilled dosing pens and cartridges and also as a powder in vials and cartridges to be mixed with liquid to be injected subcutaneously (under the skin). When somatropin injection is given to replace growth hormone in adults, it is usually given once a day. Somatropin injection (Serostim) is used to increase body weight and physical endurance in patients with human immunodeficiency virus (HIV) who have HIV-associated wasting syndrome. Somatropin injection (Zorbtive) is used to treat short bowel syndrome in adults who are receiving additional nutrition or fluids from intravenous (IV) therapy. Somatropin is a human growth hormone (hGH) analog. It works by replacing growth hormones that are normally produced in the body, which may result in increased growth, body weight, and improved absorption of nutrients and fluids from the intestines.

Market Dynamics

Increasing product approval by regulatory authorities is expected to fuel growth of the global somatropin market over the forecast period. For instance, on January 13, 2022, Ascendis Pharma A/S, a company that manufactures pharmaceutical products announced that the European Commission (EC) granted marketing authorization for Lonapegsomatropin Ascendis Pharma (developed under the name TransCon hGH) as a once-weekly subcutaneous injection for the treatment of children and adolescents aged 3 to 18 years with growth failure due to insufficient secretion of endogenous growth hormone (also known as growth hormone deficiency, or GHD). TransCon hGH is a prodrug of somatropin that provides sustained release of unmodified somatropin (hGH) at predictable therapeutic levels in the body.

Key features of the study:

  • This report provides an in-depth analysis of the global somatropin market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global somatropin market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Novo Nordisk A/S, Pfizer, Inc., Eli Lilly and Company, AnkeBio Co. Ltd., Reliance Life Sciences, GeneScience Pharmaceuticals, Zhongshan Sinobioway Hygene Biomedicine Co., Ltd., JCR Pharmaceuticals Co., Ltd., Sandoz International GmbH, Ipsen Pharma, LG Chem, Merck KGaA, Genentech, Inc., Ferring B.V., and USV Limited
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global somatropin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global somatropin market
Detailed Segmentation:
  • Global Somatropin Market, By Dosage Form:
  • Powder
  • Solvent
  • Global Somatropin Market, By Application :
  • Growth Hormone Deficiency (GHD)
  • Turner Syndrome
  • Chronic Renal Insufficiency
  • Prader Willi Syndrome
  • Small for Gestational Age
  • SHOX Deficiency
  • Others
  • Global Somatropin Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Somatropin Market, By Region:
  • North America
By Country
  • U.S.
  • Canada
  • Latin America
By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
By Region/Country
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • Novo Nordisk A/S *
Company Highlights

Products Portfolio

Key Highlights

Financial Performance

Strategies
  • Pfizer, Inc.
  • Eli Lilly and Company
  • GeneScience Pharmaceuticals
  • Sandoz International GmbH
  • Ipsen Pharma
  • LG Chem
  • Merck KGaA
  • Genentech, Inc.
  • Ferring B.V.
  • AnkeBio Co., Ltd
  • USV Limited
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Dosage Form
Market Snapshot, By Application
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Opportunity
Impact Analysis
Key Developments
Industry Trends
Regulatory Scenario
Recent Product Approval/Launches
PEST Analysis
Porter’s Analysis
4. Global Somatropin Market– Impact of Coronavirus (COVID-19) Pandemic
Impact on Demand
Impact on Healthcare
Epidemiology
5. Global Somatropin Market, By Dosage Form, 2017 – 2030, (US$ Bn)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Powder
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Bn)
Solvent
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
6. Global Somatropin Market, By Application, 2017 – 2030, (US$ Bn)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Growth Hormone Deficiency (GHD)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Bn)
Turner Syndrome
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
Chronic Renal Insufficiency
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
Prader Willi Syndrome
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Bn)
Small for Gestational Age
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
SHOX Deficiency
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
7. Global Somatropin Market, By Distribution Channel, 2017 – 2030, (US$ Bn)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Bn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Bn)
8. Global Somatropin Market, By Region, 2017 – 2030 (US$ Billion)
Introduction
Market Share Analysis, By Region, 2022 and 2030(%)
Y-o-Y Growth Analysis, For Regions, 2017 - 2030
Regional Trends
North America
Market Size and Forecast, By Dosage Form, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By Application, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By Distribution Channel, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By Country, 2017 – 2030 (US$ Bn)
U.S.
Canada
Latin America
Market Size and Forecast, By Dosage Form, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By Application, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By Distribution Channel, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By Country, 2017 – 2030 (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Market Size and Forecast, By Dosage Form, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By Application, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By Distribution Channel, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By Country, 2017 – 2030 (US$ Bn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Dosage Form, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By Application, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By Distribution Channel, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By Country, 2017 – 2030 (US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Market Size and Forecast, By Dosage Form, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By Application, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By Distribution Channel, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By Country, 2017 – 2030 (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
Market Size and Forecast, By Dosage Form, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By Application, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By Distribution Channel, 2017 – 2030 (US$ Bn)
Market Size and Forecast, By Region/Country, 2017 – 2030 (US$ Bn)
South Africa
Central Africa
North Africa
9. Competitive Landscape
Heat Map Analysis
Market Share Analysis
Novo Nordisk A/S
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Pfizer, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Eli Lilly and Company
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
GeneScience Pharmaceuticals
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Sandoz International GmbH
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Ipsen Pharma
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
LG Chem
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Merck KGaA
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Genentech, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Ferring B.V.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
AnkeBio Co., Ltd
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
USV Limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views
10. Section
Research Methodology
About Us
*Browse 40 market data tables and 48 figures on “Global Somatropin Market” - forecast to 2030

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings